Hong Yuan Holding Group (HGYN) Stock

About Hong Yuan Holding Group

Hong Yuan Holding Group presently conducts no substantial business operations. Historically, the company's primary focus lay in the advancement and commercialization of bio-derived resins. It operated under the name Cereplast, Inc. until June 2021, when it officially adopted its current designation. Established in 2001, the entity's headquarters are situated in Zhengzhou, China.

Hong Yuan Holding Group is headquartered in CN.

Hong Yuan Holding Group (HGYN) stock trades at $0.03 with a market capitalization of $2.43M. The stock is valued at a price-to-earnings (P/E) ratio of 108.33, a negative price-to-book of -15.91, reflecting negative shareholders' equity, price-to-sales of 3.79. Over the past 52 weeks the stock has ranged between $0.00 and $0.24, and currently trades 87.5% below its 52-week high.

On profitability, Hong Yuan Holding Group generates a return on equity (ROE) of -20.00% (not meaningful, as shareholders' equity is negative), return on capital employed of -61.58%, an operating margin of 6.52%, a net profit margin of 3.82%.

Official website: www.cereplast.com